Ann: Completion of first commercial scans at I-MED, page-23

4DMEDICAL COMMENCES PATIENT RECRUITMENT FOR
VENTILATION-PERFUSION (VQ) CLINICAL TRIAL

Highlights
• 4DMedical has successfully recruited and scanned the first cohort of participants in its VentilationPerfusion (VQ) clinical trial at the University of Miami – four months ahead of schedule
• 4DMedical’s VQ product is the second product in line for commercialisation and is designed to compete
with nuclear medicine scans without the use of radioactive contrast agents
• The clinical trial will involve the recruitment of approximately 70 participants and will directly compare
4DMedical’s VQ outputs against that of traditional nuclear medicine VQ
• The clinical trial will assist the Company to validate its VQ product in preparation to submit an
application to the U.S. Food & Drug Administration (FDA) in 2022